Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-09-06
2005-09-06
Park, Hankyel T. (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C530S350000, C536S023200
Reexamination Certificate
active
06939689
ABSTRACT:
This invention provides methods of obtaining novel polynucleotides and encoded polypeptides by the use of non-stochastic methods of directed evolution (DirectEvolution™). A particular advantage of exonuclease-mediated reassembly methods is the ability to reassemble nucleic acid strands that would otherwise be problematic to chimerize. Exonuclease-mediated reassembly methods can be used in combination with other mutagenesis methods provided herein. These methods include non-stochastic polynucleotide site-saturation mutagenesis (Gene Site Saturation Mutagenesis™) and non-stochastic polynucleotide reassembly (GeneReassembly™). This invention provides methods of obtaining novel enzymes that have optimized physical &/or biological properties. Through use of the claimed methods, genetic vaccines, enzymes, small molecules, and other desirable molecules can be evolved towards desirable properties. For example, vaccine vectors can be obtained that exhibit increased efficacy for use as genetic vaccines. Vectors obtained by using the methods can have, for example, enhanced antigen expression, increased uptake into a cell, increased stability in a cell, ability to tailor an immune response, and the like. Furthermore, this invention provides methods of obtaining a variety of novel biologically active molecules, in the fields of antibiotics, pharmacotherapeutics, and transgenic traits.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 4800159 (1989-01-01), Mullis et al.
patent: 4959312 (1990-09-01), Sirotkin
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5176995 (1993-01-01), Sninsky et al.
patent: 5187083 (1993-02-01), Mullis
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5223408 (1993-06-01), Goeddel et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5234824 (1993-08-01), Mullis
patent: 5284485 (1994-02-01), Thompson et al.
patent: 5333675 (1994-08-01), Mullis et al.
patent: 5354656 (1994-10-01), Sorge et al.
patent: 5389537 (1995-02-01), Raines et al.
patent: 5512463 (1996-04-01), Stemmer
patent: 5605793 (1997-02-01), Stemmer
patent: 5645988 (1997-07-01), Vande Woude et al.
patent: 5658727 (1997-08-01), Barbas et al.
patent: 5723323 (1998-03-01), Kauffman et al.
patent: 5759817 (1998-06-01), Barbas
patent: 5763192 (1998-06-01), Kauffman et al.
patent: 5789166 (1998-08-01), Bauer et al.
patent: 5798208 (1998-08-01), Crea
patent: 5811238 (1998-09-01), Stemmer et al.
patent: 5814476 (1998-09-01), Kauffman et al.
patent: 5817483 (1998-10-01), Kauffman et al.
patent: 5824469 (1998-10-01), Horwitz et al.
patent: 5824514 (1998-10-01), Kauffman et al.
patent: 5830721 (1998-11-01), Stemmer et al.
patent: 5830996 (1998-11-01), Ireland et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5866363 (1999-02-01), Pieczenik
patent: 5885577 (1999-03-01), Alvarez
patent: 5885827 (1999-03-01), Wabl et al.
patent: 5932419 (1999-08-01), Bauer et al.
patent: 5939250 (1999-08-01), Short
patent: 5945329 (1999-08-01), Breddam et al.
patent: 5965408 (1999-10-01), Short
patent: 5976862 (1999-11-01), Kauffman et al.
patent: 6004788 (1999-12-01), Short
patent: 6054267 (2000-04-01), Short
patent: 6057103 (2000-05-01), Short
patent: 6171820 (2001-01-01), Short
patent: 6238884 (2001-05-01), Short et al.
patent: 6335179 (2002-01-01), Short
patent: 6352842 (2002-03-01), Short et al.
patent: 6358709 (2002-03-01), Short et al.
patent: 6361974 (2002-03-01), Short et al.
patent: 0 285 123 (1988-10-01), None
patent: 0 316 018 (1989-05-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 91/12341 (1991-08-01), None
patent: WO 91/16427 (1991-10-01), None
patent: WO 95/20039 (1995-07-01), None
patent: WO 95/22625 (1995-08-01), None
patent: WO 96/06188 (1996-02-01), None
patent: WO 96/09411 (1996-03-01), None
patent: WO 96/41865 (1996-12-01), None
patent: WO 97/20078 (1997-06-01), None
patent: WO 97/20950 (1997-06-01), None
patent: WO 97/35957 (1997-10-01), None
patent: WO 98/01581 (1998-01-01), None
patent: WO 98/13487 (1998-04-01), None
patent: WO 98/27230 (1998-06-01), None
patent: WO 98/32845 (1998-07-01), None
patent: WO 98/38297 (1998-09-01), None
patent: WO 98/42832 (1998-10-01), None
patent: WO 98/45331 (1998-10-01), None
patent: WO 98/48024 (1998-10-01), None
patent: WO 98/49286 (1998-11-01), None
patent: WO 98/58080 (1998-12-01), None
patent: WO 99/36553 (1999-07-01), None
patent: WO 00/52146 (2000-09-01), None
patent: WO 00/52153 (2000-09-01), None
patent: WO 00/52155 (2000-09-01), None
patent: WO 00/52180 (2000-09-01), None
patent: WO 01/30998 (2001-05-01), None
patent: WO 01/31035 (2001-05-01), None
patent: WO 01/31049 (2001-05-01), None
patent: WO 01/42455 (2001-06-01), None
Arkin and Youvan, “Optimizing nucleotide mixtures to encode specific subsets of amino acids for semi-radom mutagenesis,”Bio-technology(NY) 10(3): 297-300 (Mar. 1992).
Burks et al., “In vitro scanning saturation mutagenesis of an antibody binding pocket,”Proc Natl Acad Sci USA94(2): 412-417 (Jan. 21, 1997).
Chen and Struhl, “Saturation mutagenesis of a yeast his3 “TATA element”: genetic evidence for a specific TATA-binding protein,”Proc Natl Acad Sci USA85(8): 2691-2695 (Apr. 1988).
Chiang et al., “Mutagenic oligonucleotide-directed PCR amplification (Mod-PCR): an efficient random base substitution mutations in a DNS sequence element,”PCR Methods Appl2(3): 210-217 (Feb. 1993).
Christian et al, “Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage,”J Mol Biol227(3): 711-718 (Oct. 5, 1992).
Cunniff and Mrogan, “Analysis of heat shock element recognition by saturation mutagenesis of the human HSP70.1 gene promoter,”J Biol Chem268(11): 8317-8324 (Apr. 15, 1993).
Cwirla et al., “Peptide on a phage: a vast library of peptides for identifying ligands,”Proc Natl Acad Sci USA87(16): 6378-6382 (Aug. 1990).
Delagrave and Youvan, “Searching Sequence Space to Engineer Proteins: Exponential Ensemble Mitagenesis,”Bio/Technology,11: 1548-1552 (Dec. 1993).
Dennis and Lazarus, “Kunitz domain inhibitors of tissue factor-factor VIIa. I. Potent inhibitors selected from libraries by phage display,”J Biol Chem269(35): 22129-22136 (Sep. 2, 1994).
Derbyshire et al., “A simple and efficient procedure for saturation mutagenesis using mixed oligodeoxynucleotides,”Gene46(2-3): 145-152 (1986).
Gogg et al., “Efficient saturation mutagenesis of apentapeptide coding sequence using mixed oligonucleotides,”DNA6(4): 381-388 (Aug. 1987).
Hill and Struhl, “Mutagenesis with degenerate oligonucleotides: and efficient method for saturating a defined DNA region with base pair substitutions,”Methods Enzymol155: 558-568 (1987).
Horwitz and DiMaio, “Saturation mutagenesis using mixed oligonucleotides and M13 templates containing uracil,”Methods Enzymol185: 599-611 (1990).
Ihara et al., Requirement of the Pro-Cys-His-Arg sequence for O6-methylguanine DNA methylransferase activity revealed by saturation mutagenesis with negative and positive screening,Mol Gen Genet243(4): 379-389 (May 25, 1994).
J.W. Little, “Saturation mutagenesis of specific codons: elimination of molecule with stop codons from mixed pools of DNA,”Gene88(1): 113-115 (Mar. 30, 1990).
Morris and McIvor, “Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance,”Biochem Pharmacol47(7): 1207-1220 (Mar. 29, 1994).
Olesen and Kielland-Brandt, “Altering substrate preference of acarboxypeptidase Y by a novel strategy of mutagenesis eliminating wild type backgroun,”Protein Eng6(4): 409-415 (Jun. 1993).
Olins et al., “Saturation mutagenesis of human interleukin-3,”J Biol Chem270(40): pp 23754-123760 (Oct. 6, 1995).
Oliphant and Struhl, “An efficient method for generation proteins with altered enzymatic properties: application to beta-la
Djavakhishvili Tsotne David
Frey Gerhard Johann
Short Jay M.
Diversa Corporation
Park Hankyel T.
LandOfFree
Exonuclease-mediated nucleic acid reassembly in directed... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Exonuclease-mediated nucleic acid reassembly in directed..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Exonuclease-mediated nucleic acid reassembly in directed... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3449220